To Evaluate the Safety and Efficacy of NVP-2203 Tablet in Patients

Status:
Not yet recruiting

Trial end date:
2024-10-31

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the efficacy and safety NVP-2203 in patients

Phase 3

NVP Healthcare